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was slightly distended but hepatosplenomegaly was not 
observed. Laboratory data showed: white blood cell count 
15,010 /μL, red blood cell count 379 × 104 /μL, hemo-
globin 12.4 g/dL, hematocrit 36.7 %, platelet count 30.3 × 
104 /μL, total protein 6.4 g/dL, albumin 3.0 g/dL, total biliru-
bin 2.5 mg/dL, aspartate aminotransferase 112 IU/L, alanine 
aminotransferase 67 IU/L, lactate dehydrogenase 660 IU/L, 
creatine phosphokinase 63 IU/L, blood urea nitrogen 5 mg/
dL, creatinine 0.30 mg/dL, C-reactive protein 13.3 mg/dL, 
immunoglobulin (Ig) G 945 mg/dL, IgA 3 mg/dL and IgM 
91 mg/dL. Neither pyuria nor pleocytosis were present. Oph-
thalmological examination confirmed that there was no uvei-
tis. At 6 days old, small red papules appeared on the skin of 
the patient’s entire body. No significant pathogens were cul-
tured from her urine, blood, stool, spinal fluid or pharyngeal 
secretion and no virus was isolated from her stool and phar-
yngeal secretion.
Antibacterial and antiviral agents were infused but the 
fever persisted. At the age of 16 days, the patient became 
sluggish and abdominal distension increased with watery 
diarrhea. C-reactive protein markedly elevated to 41.2 mg/
dL. Computed tomography scan showed dilatation of the 
intestine, edematous intestinal walls and retention of the 
intestinal contents. Serum IgE increased to 367.8 IU/mL 
and IgE specific for cow’s milk to 4.07 IU/mL. Both human 
and formula milk were ceased. The fever declined gradu-
ally, she became active, and the abdominal distension and 
diarrhea improved. Human milk and elemental diet were 
tolerated, but re-introduction of formula milk induced fever 
and watery diarrhea again. Urine concentrations of meva-
lonic acid in the afebrile and febrile periods were elevated 
to 26.5 and 35.9 µg/mg Cr, respectively. Mevalonate kinase 
activity with respect to control values was 1.3 % and Meva-
lonate kinase gene analysis revealed a compound heterozy-
gous mutation [c.613A > G/c.382_383 del AG].
To the Editor,
Mevalonate kinase deficiency (MKD) is a rare autoin-
flammatory disease characterized by recurrent fever, lym-
phadenopathy, hepatomegaly, splenomegaly, skin lesions, 
abdominal pain, and diarrhea [1–4] and may lead to neu-
rological involvement and death [1, 5]. The febrile attack is 
commonly triggered by infection, vaccines, and stress. We 
report an infant with MKD whose febrile attacks were trig-
gered by milk allergy.
The female patient was born by cesarean section because 
of obstructed labor at a gestational age of 39 weeks and 
4 days with a birth weight of 2612 g. No signs of infection 
were seen in the gestation and peripartum period. Her father 
was Hispanic and her mother Asian. At 3 days of age, her 
body temperature rose above 38 °C, and the next day she 
was transferred to the neonatal intensive care unit of Seirei 
Hamamatsu General Hospital, Shizuoka, Japan. On admis-
sion, the patient’s activity was maintained, and she could 
feed breast and formula milk adequately. Body temperature 
was 39.0 °C and mild tachypnea was observed. No aphthous 
ulcers in the oral cavity were observed. Breath sounds were 
normal and heart murmurs were not audible. The abdomen 
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In MKD, the inflammasome, which converts pro-IL1β 
to IL1β and causes fever, is activated excessively by exog-
enous and endogenous microbial products [4–6]. The dis-
ease is caused by the lack of isoprenoids (mevalonate path-
way products), and mevalonic aciduria is characteristic. 
The inflammatory responses in this case were too strong 
to be induced by milk allergy alone, thus we predicted the 
co-existence of another inflammatory disease. Although the 
mechanism is not precisely understood, tissue damage by 
milk allergy may activate the inflammasome.
At 2 months of age, febrile attack can be avoided by 
disuse of formula milk. Later, however, attacks may be 
induced by things such as initiation of vaccinations and 
common colds. If attacks occur repeatedly, anti-inflamma-
tory drugs such as IL-1 blockers should be introduced to 
prevent severe complications.
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